Skip to main content

Market Overview

Jefferies & Company Reiterates Hold Rating, $38 PT for St. Jude Medical

Share:

In a report published earlier today, Jefferies & Company, Inc. reiterated its Hold rating and $38.00 for St. Jude Medical, Inc. (NYSE: STJ).

Jefferies went on to say “STJ issued a release on Friday with its findings on the Durata failure recently reported in FDA's MAUDE database. After examining the lead at the hospital in FL where it was removed, the root cause was found to be external abrasion and not the more damning insideout mode. While the company's findings maintain Durata's pristine record with inside-out externalizations, concern over STJ ICD leads persists and we maintain our Hold rating.”

St. Jude Medical, Inc. closed on Friday at $37.90.

Latest Ratings for STJ

DateFirmActionFromTo
Jul 2016WedbushDowngradesOutperformNeutral
Jul 2016Leerink SwannDowngradesOutperformMarket Perform
May 2016BarclaysDowngradesOverweightEqual-Weight

View More Analyst Ratings for STJ

View the Latest Analyst Ratings

 

Related Articles (STJ)

View Comments and Join the Discussion!

Posted-In: Jefferies & Company Inc.Analyst Color Reiteration Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com